The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Cardiovascular Control Mechanisms in the Conscious State
1975 • 387 citations
Membrane Active Drugs and the Aggregation of Human Blood Platelets
1967 • 173 citations
Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for evaluation of anti-thrombotic agents
1980 • 168 citations
STIMULATION OF PROSTACYCLIN RELEASE FROM VESSEL WALL BY BAY g 6575, AN ANTITHROMBOTIC COMPOUND
1979 • 108 citations
The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro
1981 • 60 citations
Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound bay g 6575
1980 • 58 citations
Cardioprotective Effects of Ibuprofen in Experimental Regional and Global Myocardial Ischemia
1982 • 54 citations
The antithrombotic activity of BAY g 6575.
1979 • 38 citations
Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
1982 • 28 citations
The effect of diltiazem on coronary thrombosis in the conscious canine
1982 • 12 citations
Cited By (0)
No citing papers found in database